This episode we have updates for you from the FDA for approval of Ongentys for Parkinson’s symptoms and approval of the MenQuadfi vaccine, a meningococcal conjugate vaccine. We also have new indication and age approvals for Zejula for ovarian cancer, Jublia for onychomychosis, and Keytruda for multiple types of cancer. We'll be giving our regular update on coronavirus numbers in the next episode this week. Don't forget to like, share, and subscribe! Enjoy!